ETV Bharat / bharat

Digital transformation spending set to grow in 2020 despite pandemic misery

Amid growing concerns over the coronavirus pandemic, spending on digital transformation (DX) will not slow down rather flourish at a solid pace, according to new data from the International Data Corporation.

Representative Image
Representative Image
author img

By

Published : May 22, 2020, 1:46 AM IST

Hyderabad: Despite the challenges presented by the COVID-19 pandemic, spending on the digital transformation (DX) of business practices, products, and organizations will continue at a rapid pace, according to new data from the International Data Corporation (IDC).

Spending on DX technologies and services is forecast to grow 10.4% worldwide in 2020 to an eye-watering US$1.3 trillion, highlighting the growing significance being placed on the adoption of emerging technologies.

Of the 278 DX use cases identified in the IDC’s DX Spending Guide, only nine will see a decline in spending this year.

Craig Simpson, IDC senior research manager of customer insights, said that COVID-19 has upended the global economy, with direct negative implications on the way businesses invest in IT.

Read: Learn about Clinical Trials Day and why we celebrate it

"DX technology investment has not gone unscathed, but so far it has been affected to a lesser extent since many large-scale DX projects underway or planned are instrumental to broader strategic business initiatives. Compared to IDC's pre-COVID-19 forecast, the five-year growth rate for DX spending has declined by less than two percentage points," he added.

Research from IDC’s report confirms that the degree of economic hardship experienced as a result of the pandemic is directly tied to the degree of digital transformation growth in 2020.

Eileen Smith, IDC program vice president of customer insights, said that COVID-19 has wiped off almost $500 billion of worldwide DX technology investment between 2020-2023 from our pre-COVID-19 forecast.

"Yet despite these losses, pockets of growth opportunities exist across most industries when diving deep into specific use cases that solve specific business problems. A few examples include RPA-based claims processing in insurance, digital visualisation in education, omnichannel commerce platforms in telecommunications, and clinical trial operational excellence in process manufacturing," he added.

Read: India supports move at WHO to seek origin of coronavirus

The United States will remain the largest geographic market for DX spending, delivering roughly one-third of the worldwide total in 2020.

Western Europe will be the second-largest region for DX spending, following closely by China. These two regions will also deliver the strongest year-over-year growth in DX spending at 13.6% for China and 12.8% for Western Europe.

It is pertinent to mention here that the IDC's Spending Guides provide a granular view of key technology markets from a regional, vertical industry, use case, buyer, and technology perspective. The spending guides are delivered via a pivot table format or custom query tool, allowing the user to easily extract meaningful information about each market by viewing data trends and relationships.

Also Read: No approved treatments yet for COVID-19: WHO

Hyderabad: Despite the challenges presented by the COVID-19 pandemic, spending on the digital transformation (DX) of business practices, products, and organizations will continue at a rapid pace, according to new data from the International Data Corporation (IDC).

Spending on DX technologies and services is forecast to grow 10.4% worldwide in 2020 to an eye-watering US$1.3 trillion, highlighting the growing significance being placed on the adoption of emerging technologies.

Of the 278 DX use cases identified in the IDC’s DX Spending Guide, only nine will see a decline in spending this year.

Craig Simpson, IDC senior research manager of customer insights, said that COVID-19 has upended the global economy, with direct negative implications on the way businesses invest in IT.

Read: Learn about Clinical Trials Day and why we celebrate it

"DX technology investment has not gone unscathed, but so far it has been affected to a lesser extent since many large-scale DX projects underway or planned are instrumental to broader strategic business initiatives. Compared to IDC's pre-COVID-19 forecast, the five-year growth rate for DX spending has declined by less than two percentage points," he added.

Research from IDC’s report confirms that the degree of economic hardship experienced as a result of the pandemic is directly tied to the degree of digital transformation growth in 2020.

Eileen Smith, IDC program vice president of customer insights, said that COVID-19 has wiped off almost $500 billion of worldwide DX technology investment between 2020-2023 from our pre-COVID-19 forecast.

"Yet despite these losses, pockets of growth opportunities exist across most industries when diving deep into specific use cases that solve specific business problems. A few examples include RPA-based claims processing in insurance, digital visualisation in education, omnichannel commerce platforms in telecommunications, and clinical trial operational excellence in process manufacturing," he added.

Read: India supports move at WHO to seek origin of coronavirus

The United States will remain the largest geographic market for DX spending, delivering roughly one-third of the worldwide total in 2020.

Western Europe will be the second-largest region for DX spending, following closely by China. These two regions will also deliver the strongest year-over-year growth in DX spending at 13.6% for China and 12.8% for Western Europe.

It is pertinent to mention here that the IDC's Spending Guides provide a granular view of key technology markets from a regional, vertical industry, use case, buyer, and technology perspective. The spending guides are delivered via a pivot table format or custom query tool, allowing the user to easily extract meaningful information about each market by viewing data trends and relationships.

Also Read: No approved treatments yet for COVID-19: WHO

ETV Bharat Logo

Copyright © 2025 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.